|
|
|
|
|
|
|
|
128th MAINE LEGISLATURE |
|
|
LD 952 |
|
LR 1530(01) |
|
|
|
An Act To Ensure
Access to Opiate Addiction Treatment in Maine |
|
Preliminary
Fiscal Impact Statement for Original Bill |
|
Sponsor: Sen. Woodsome of York |
|
Committee: Health and Human Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary
Fiscal Impact Statement |
|
|
|
|
|
|
|
|
|
|
FY 2017-18 |
FY 2018-19 |
Projections FY 2019-20 |
Projections FY 2020-21 |
Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$1,016,715 |
$954,483 |
$954,483 |
$954,483 |
|
|
|
|
|
|
|
Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$1,016,715 |
$954,483 |
$954,483 |
$954,483 |
|
Federal Expenditures Fund |
|
$1,784,905 |
$1,722,137 |
$1,722,137 |
$1,722,137 |
|
|
|
|
|
|
|
Revenue |
|
|
|
|
|
|
Federal Expenditures Fund |
|
$1,784,905 |
$1,722,137 |
$1,722,137 |
$1,722,137 |
|
|
|
|
|
|
|
Fiscal Detail
and Notes |
|
|
|
|
|
|
The Department of
Health and Human Services will require General Fund appropriations of
$1,016,715 in fiscal year 2017-18 and $954,483 in fiscal year 2018-19 to
increase the MaineCare reimbursement rate for outpatient opioid treatment to
$80 per week and for a 3rd-party consultant to conduct a rate study regarding
reimbursement to outpatient opioid treatment providers. Federal Expenditures
Fund allocations will also be required for the FMAP match.
The bill also authorizes opioid treatment programs to operate without
maintaining a pharmacist in charge but requires opioid treatment programs to
enter into a written agreement with a licensed pharmacist to serve as a
consultant to the opioid treatment program and it authorizes registered professional
nurses, certified nurse practitioners and licensed practical nurses to
dispense opioid medication for substance abuse treatment purposes to patients
in an opioid treatment program. Any impact from these changes is unable to be
determined at this time. |
|
|
|
|
|
|
|